Funding
← Back to your selection

ClavystBio

Activity from announced rounds

All recorded activity
Rounds participated in
3
Confirmed lead rounds
0
2 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$122.4M
3 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1
Series C+1

By primary sector

Healthtech2
Biotech1

By country

United States2
Netherlands1

Rounds

3 in all activity
Zenflow

A minimally invasive implant system designed to relieve urinary symptoms caused by an enlarged prostate.

$52MSeries D
Participant
Leyden Laboratories

Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections.

€40MSeries B
Role not disclosed
Rejoni

Develops a hydrogel system to treat uterine health conditions and prevent scarring

$25MSeries A
Role not disclosed